paclitaxel,bevacizumab,pazopanib
roche,novartis
['pazopanib', 'bevacizumab', 'paclitaxel', 'ovarian']
adding #pazopanib to #paclitaxel did not improve efficacy, increased toxicity, and compromised chemo delivery in recurrent #ovariancancer progressing during maintenance #bevacizumab #tapaz 
Gynecologic Oncology & Gynecologic Oncology Reports Official Jnls @SGO_org Editors-in-Chief @David_Cohn_MD @SusanModesitt #SocialMediaEditor @GreggNelsonERAS